What is the clinical evidence from this study?

Study design: Other. Population: Cardiac remodeling in offspring exposed to gestational diabetes mellitus. Intervention: Maternal gestational diabetes exposure vs. Unexposed offspring (implied). Primary outcome: Structural and molecular alterations in the heart (cardiac morphometry, p53/miR-34a/SIRT1/SIRT7 expression).

What question did this study set out to answer?

This research aims to understand how gestational diabetes affects the cardiac development of offspring by exploring specific molecular pathways.

May 16, 2026Open Access

The Progression of Cardiac Damage in the Offspring of Mothers with Gestational Diabetes Is Regulated by the p53/miR-34/SIRT1/7 Pathway

Key Result

Maternal gestational diabetes exposure induced early and sustained cardiac remodeling in offspring, associated with dysregulation of the p53–miR-34a–SIRT1/SIRT7 axis.

Key Points

This research aims to understand how gestational diabetes affects the cardiac development of offspring by exploring specific molecular pathways.
Cardiac morphometry assessed at birth and 8, 15, 25, and 35 days.
Left ventricles examined with hematoxylin/eosin staining and immunofluorescence.
Molecular interactions analyzed using IPA software.
Offspring exposed to GDM had decreased cardiac area and increased left ventricular wall thickness.
miR-34a increased early, before p53 upregulation.
SIRT1 levels decreased over time, while SIRT7 remained elevated.

Structured PICO

Population

Offspring exposed to maternal gestational diabetes mellitus (GDM)

Intervention

Maternal gestational diabetes mellitus (GDM) exposure

Comparator

Unexposed offspring (implied)

Outcome

Structural and molecular alterations in the heart (cardiac morphometry, left ventricular wall thickness, fibrosis, cardiomyocyte area, and expression of SIRT1, SIRT7, Bcl-2, Bax, p53, miR-34a)surrogate

Maternal gestational diabetes induces early postnatal cardiac remodeling and dysregulation of the p53-miR-34a-SIRT1/SIRT7 axis in offspring, suggesting a mechanism for increased susceptibility to diabetic cardiomyopathy.

Abstract

Gestational diabetes mellitus (GDM) exposes the fetus to chronic hyperglycemia, promoting early cardiac remodeling and increasing the risk of diabetic cardiomyopathy later in life. Epigenetic regulators such as p53 tumor suppressor gene (p53), microRNA-34a (miR-34a), and the sirtuins 1 and 7 (SIRT1/SIRT7) may contribute to this programming process; however, their temporal dynamics during postnatal cardiac development remain unclear. This study aimed to characterize structural and molecular alterations in the hearts of offspring exposed to GDM and to determine the involvement of the p53–miR-34a–SIRT1/SIRT7 axis in early cardiac remodeling. Cardiac morphometry was assessed at birth (newborn NB) and at 8, 15, 25, and 35 days. Left ventricles were examined through hematoxylin/eosin staining. SIRT1, SIRT7, Bcl-2, and Bax were evaluated by immunofluorescence, while p53 and miR-34a were evaluated by RT-PCR. Molecular interactions were integrated using IPA software, version 159584291. Offspring exposed to GDM exhibited a reduced cardiac area and ventricular lumen, along with increased left ventricular wall thickness and fibrosis during early postnatal stages. The cardiomyocyte area was elevated at all ages. The level of miR-34a increased early, preceding p53 upregulation. SIRT1 presences decreased from NB to 35 days, whereas SIRT7 expression remained consistently elevated. These findings suggest that GDM induces early and sustained cardiac remodeling associated with dysregulation of the p53–miR-34a–SIRT1/SIRT7 axis, a pattern that could increase susceptibility to diabetic cardiomyopathy.